Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

NCT01389479 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluviral™
BIOLOGICAL: Fluzone®

Sponsor

GlaxoSmithKline

Collaborators

[object Object]